Millennium Management’s China Pharma Holdings CPHI Stock Holding History

Millennium Management’s Portfolio CPHI Stock Details CPHI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-5,561	Closed	-$33.6K	–	6242
2023 Q4	$33.6K	Buy	5,561 +3,625	+187%	+$20.3K	﹤0.01%	5544
2023 Q3	$14.3K	Buy	1,936 +1,203	+164%	+$14.6K	﹤0.01%	5709
2023 Q2	$12.5K	Sell	733 -339	-32%	-$5.96K	﹤0.01%	5721
2023 Q1	$21K	Buy	1,072 +564	+111%	+$23K	﹤0.01%	5850
2022 Q4	$24K	Buy	508 +447	+733%	+$27.3K	﹤0.01%	5997
2022 Q3	$4K	Sell	61 -81	-57%	-$7.99K	﹤0.01%	6839
2022 Q2	$15K	Buy	142 +94	+196%	+$12.6K	﹤0.01%	6560
2022 Q1	$9K	Buy	+48	New	+$10K	﹤0.01%	6741
2021 Q3	–	Sell	-58	Closed	-$21K	–	6839
2021 Q2	$21K	Buy	+58	New	+$20.9K	﹤0.01%	6426

Other funds holding CPHI

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Millennium Management's CPHI Position: Q1 2024 in Review

Millennium Management sold out of China Pharma Holdings (CPHI) in Q1 2024, closing a stake of 5,561 shares — an estimated $33.6K sold.

Millennium Management first reported a position in CPHI in Q2 2021 and held it in 9 quarters. The position peaked at $33.6K in Q4 2023. 3 funds tracked by Wall St. Rank hold CPHI as of Q1 2024.

Millennium Management reported no remaining China Pharma Holdings position as of Q1 2024 after selling out during the quarter.
Millennium Management sold 5,561 China Pharma Holdings shares in Q1 2024, an estimated $33.6K.
Millennium Management first reported a position in China Pharma Holdings in Q2 2021 and held it in 9 quarters.
Millennium Management's China Pharma Holdings position peaked at $33.6K in Q4 2023.
3 funds tracked by Wall St. Rank held China Pharma Holdings as of Q1 2024.

Based on Millennium Management's 13F filing for Q1 2024, filed 15 May 2024.